Loading market dashboard
SymBio Pharmaceuticals Limited
SYMQYHealthcareOTCJP
Loading analysis workspace
Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
SymBio Pharmaceuticals Limited · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2024 | $17.54B | $17.54B - $17.54B | -$6.27B | $60.702 | 1 |
| Dec 2023 | $7.37B | $7.37B - $7.37B | -$2.64B | -$10.005 | 1 |
| Dec 2022 | $9.34B | $9.34B - $9.34B | -$3.34B | $39.598 | 1 |
| Dec 2021 | $9.13B | $9.13B - $9.13B | -$3.26B | $29.584 | 1 |
| Dec 2020 | $3.00B | $3.00B - $3.00B | -$1.07B | -$121.752 | 1 |
| Dec 2019 | $3.04B | $3.04B - $3.04B | -$1.09B | -$170.46 | 1 |
| Dec 2018 | $4.10B | $4.10B - $4.10B | -$1.47B | -$179.854 | 1 |
| Dec 2017 | $3.62B | $3.62B - $3.62B | -$1.29B | -$330.767 | 1 |
| Dec 2016 | $2.11B | $2.11B - $2.11B | -$755.52M | -$319.895 | 1 |
| Dec 2015 | $1.92B | $1.92B - $1.92B | -$685.80M | -$314.00 | 1 |